Longevity & Aging Newsletter
Issue #2September 15, 20257 studies

Targeting dormant cancer cells cuts recurrence by 80-87% in breast cancer survivors

Targeting dormant cancer cells cuts recurrence by 80-87% in breast cancer survivors

Monday, Monday, September 15th Longevity & Aging Newsletter Issue #2

This week brought breakthroughs in targeting the cellular mechanisms that drive aging and disease - from sleeping cancer cells to metabolic clocks that predict how fast we're aging.

๐ŸŽฏ Dormant Cancer Cells Successfully Targeted in Breakthrough Trial

Researchers tackled one of cancer's biggest challenges: dormant tumor cells that hide in bone marrow and cause recurrence years later. In a phase 2 trial with 51 breast cancer survivors who had detectable dormant cells, they tested three treatments - hydroxychloroquine (HCQ), everolimus (EVE), or both combined.

  • The results were striking: 3-year recurrence-free survival rates hit 91.7% for HCQ alone, 92.9% for EVE alone, and 100% for the combination

  • All three treatments reduced dormant cell counts by 78-87% compared to no treatment, with 98-99.9% probability these reductions were real

  • The treatments were well-tolerated - only one patient stopped early due to side effects

Why this matters: This is the first human trial to successfully target dormant cancer cells, potentially preventing recurrence in the 30% of breast cancer patients who develop metastases years after initial treatment.

๐Ÿ† Top 0.1% journal ๐Ÿ”— Nature Medicine ๐Ÿ—“๏ธ Sep 2

Key Findings

๐Ÿงฌ Aging Protein EPS8 Drives Disease-Related Protein Clumps

Scientists discovered that EPS8, a protein that accumulates with age, promotes the toxic protein clumps seen in Huntington's disease and ALS. When they knocked down EPS8 in worms and human cells, it prevented protein aggregation and neurodegeneration. The key regulator? USP4, an enzyme that normally breaks down EPS8 - reducing USP4 during aging prevented EPS8 buildup and extended lifespan.

๐Ÿ’ก Age-related protein accumulation directly causes neurodegenerative diseases - targeting this pathway could prevent multiple conditions at once.
๐Ÿฅ‡ Top 1% journal ๐Ÿ”— Nature Aging ๐Ÿ—“๏ธ Sep 3

๐Ÿ”ฌ Asparagine Starvation Selectively Kills Senescent Cells

Researchers found that senescent cells (damaged cells that accumulate with age) have a critical weakness: they can't make their own asparagine amino acid. By combining L-asparaginase (which destroys external asparagine) with autophagy inhibitors (which block internal recycling), they selectively killed senescent cells in aged mice. This dual treatment reduced age-related bone loss, atherosclerosis, and fatty liver disease.

๐Ÿ’ก Senescent cells have a metabolic Achilles heel that can be exploited to reverse multiple age-related diseases simultaneously.
๐Ÿฅ‰ Top 5% journal ๐Ÿ”— Aging Cell ๐Ÿ—“๏ธ Sep 4

๐Ÿ“Š Nerve-Associated Fat Cells Control Aging Inflammation

Using single-cell sequencing, scientists mapped how different fat tissue immune cells change with age. They discovered that CD169+ nerve-associated macrophages (NAMs) decline with aging, and when depleted in old mice, inflammation increased and fat breakdown was impaired. These specialized cells appear to control both tissue inflammation and metabolic function throughout life.

๐Ÿ’ก The nervous system's immune cells in fat tissue are key regulators of healthy aging - their loss drives inflammaging.
๐Ÿฅ‡ Top 1% journal ๐Ÿ”— Nature Aging ๐Ÿ—“๏ธ Sep 2

๐Ÿงช Engineered Probiotic Yeast Fights Colon Cancer

Scientists engineered Saccharomyces boulardii yeast to secrete spermidine, a longevity-promoting molecule. In mouse models of inflammatory bowel disease and colon cancer, this engineered probiotic significantly outperformed regular S. boulardii in reducing colitis symptoms and preventing cancer development. The modified yeast successfully colonized the gut and raised local spermidine levels.

๐Ÿ’ก Engineering probiotics to produce specific longevity molecules could be a low-cost way to prevent age-related diseases.
Top 20% journal ๐Ÿ”— Scientific Reports ๐Ÿ—“๏ธ Aug 30

๐Ÿƒ Mediterranean Diet Evidence Shows Mixed Longevity Results

A comprehensive review challenged the assumption that vegetarian diets automatically increase longevity. While one 'blue zone' (areas with exceptional longevity) is largely vegetarian, most are inhabited by flexitarians who eat some meat. The analysis found a lack of high-quality evidence for vegetarian diets extending telomeres or definitively reducing mortality when objective measures were used.

๐Ÿ’ก Flexitarian diets may be just as good as strict vegetarianism for longevity - the key is overall dietary quality, not complete meat avoidance.
Top 20% journal ๐Ÿ”— Maturitas ๐Ÿ—“๏ธ Sep 3

๐Ÿ”ฌ Metabolic Clocks Predict Biological Age from Blood

Researchers developed new 'metabolomic clocks' that estimate biological age using metabolic markers measurable in blood via NMR spectroscopy. These clocks can identify disease-specific metabolic distortions and support early detection of accelerated aging. The approach combines high accuracy in age prediction with clinical interpretability for risk assessment.

๐Ÿ’ก Blood-based metabolic testing could soon tell you how fast you're aging and your risk for specific age-related diseases.

Implications

These studies reveal aging as a highly targetable process - from dormant cancer cells to senescent cell metabolism to inflammatory immune cells. The convergence on autophagy, metabolism, and cellular quality control suggests we're identifying the core mechanisms that could be manipulated to extend healthy lifespan.

Studies in this issue

Primary sources used for this newsletter.

  1. Are vegetarian diets good or bad for living longer?
    key findingMaturitas2025-09-03PMID 40902289
  2. Aging Clocks Based on Metabolic Chemicals
    key findingnpj metabolic health and disease2025-09-03PMID 40903544